Literature DB >> 14692432

Prevalence of asthmatic phenotypes and bronchial hyperresponsiveness in Turkish schoolchildren: an International Study of Asthma and Allergies in Childhood (ISAAC) phase 2 study.

Yildiz Saraçlar1, Semanur Kuyucu, Ayfer Tuncer, Bülent Sekerel, Cansin Saçkesen, Can Kocabaş.   

Abstract

BACKGROUND: Numerous epidemiologic studies have revealed that bronchial asthma affects populations without regard to frontiers. However, standardized methodological approaches are necessary to compare these populations.
OBJECTIVE: To investigate objective markers of childhood asthma on an epidemiologic basis and to include Turkish children in international comparisons.
METHODS: Parental questionnaires were collected and skin prick tests performed on fourth grade primary schoolchildren, aged 8 to 11 years, residing in Ankara, Turkey. Pulmonary function tests and bronchial challenge with hypertonic saline (HS) were conducted in children selected from this cohort with a stratified random sampling according to the presence of current wheezing.
RESULTS: A total of 3,041 questionnaires were included in the evaluation. Skin prick tests were performed on 2,774 children (97.1%). A total of 347 children from this cohort underwent pulmonary function and bronchial challenge tests. In 18 (5.1%) of the 347 children, bronchial challenge tests could not be successfully completed. The prevalence values were 11.5% for current wheezing, 6.9% for physician-diagnosed asthma, and 7.7% for physician-diagnosed recurrent bronchitis. Population-based weighted prevalence of bronchial hyperresponsiveness (BHR) was 21.8%. Frequency of responses to HS was 38.6% among physician-diagnosed asthma cases and 30.5% among patients with current wheezing. Skin test positivity was present in 38.7% of the children with a diagnosis of asthma or asthmatic bronchitis, 35.0% of current asthmatic patients, and 19.2% of patients with current wheezing.
CONCLUSIONS: Objective markers, in addition to the questionnaire-based prevalence figures, need to be used in epidemiologic surveys for asthma, especially in countries with inadequate health care facilities or problems with interpretation of the wheeze concept.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14692432     DOI: 10.1016/S1081-1206(10)61517-7

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  4 in total

1.  Prevalence of sleep-disordered breathing and associated risk factors in primary school children in urban and rural environments.

Authors:  Yasemin Gokdemir; Ersoy Civelek; Banu Cakir; Ahmet Demir; Can Naci Kocabas; Nilay Bas Ikizoglu; Fazilet Karakoc; Bulent Karadag; Refika Ersu
Journal:  Sleep Breath       Date:  2020-10-08       Impact factor: 2.816

2.  Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019.

Authors:  Burcin Beken; Gokcen Kartal Ozturk; Fatma Deniz Aygun; Cigdem Aydogmus; Himmet Haluk Akar
Journal:  Ann Allergy Asthma Immunol       Date:  2021-01-23       Impact factor: 6.347

3.  The Impact of the COVID-19 Pandemic in Adolescents with Asthma.

Authors:  Sukru Cekic; Zuhal Karali; Fatih Cicek; Yakup Canitez; Nihat Sapan
Journal:  J Korean Med Sci       Date:  2021-12-20       Impact factor: 2.153

4.  Allergy-specific Phenome-Wide Association Study for Immunogenes in Turkish Children.

Authors:  Sefayet Karaca; Ersoy Civelek; Mehmet Karaca; Umit M Sahiner; Riza K Ozgul; Can N Kocabas; Renato Polimanti; Bülent E Sekerel
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.